|
109
|
350
|
4erkA |
The complex structure of the map kinase erk2/olomoucine |
|
112
|
349
|
4f9yA |
Human p38 alpha mapk in complex with a novel and selective small molecule inhibitor |
|
65
|
291
|
4ez5A |
Cdk6 (monomeric) in complex with inhibitor |
|
68
|
276
|
4f1tA |
Crystal structure of the roco4 kinase domain from d. discoideum bound to the rock inhibitor h1152 |
|
91
|
291
|
4pmpA |
The structure of trka kinase bound to the inhibitor 1-cyclopropyl-1-[3-(1,3-thiazol-2-yl)benzyl]-3-[4-(trifluoromethoxy)phenyl]urea |
|
77
|
302
|
4ez7A |
Cdk2 in complex with staurosporine and 2 molecules of 8-anilino-1-naphthalene sulfonic acid |
|
104
|
361
|
4f6uA |
Crystal structure of human cdk8/cycc in complex with compound 5 (1-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-[3-(morpholin-4-yl)propyl]urea) |
|
100
|
356
|
4f9bA |
Human cdc7 kinase in complex with dbf4 and pha767491 |
|
101
|
359
|
4f6wA |
Crystal structure of human cdk8/cycc in complex with compound 1 (n-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-4-[2-({[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]carbamoyl}amino)ethyl]piperazine-1-carboxamide) |
|
91
|
290
|
4f09A |
Discovery and optimization of c-2 methyl imidazo-pyrrolopyridines as potent and orally bioavailable jak1 inhibitors with selectivity over jak2 |
|
107
|
349
|
4ewqA |
Human p38 alpha mapk in complex with a pyridazine based inhibitor |
|
100
|
356
|
4f9aA |
Human cdc7 kinase in complex with dbf4 and nucleotide |
|
102
|
354
|
4f9cA |
Human cdc7 kinase in complex with dbf4 and xl413 |
|
100
|
362
|
4f7nA |
Crystal structure of human cdk8/cycc in complex with compound 11 (1-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-(5-hydroxypentyl)urea) |
|
87
|
284
|
4qmnA |
Mst3 in complex with bosutinib |
|
94
|
303
|
4hw7A |
Crystal structure of fms kinase domain with a small molecular inhibitor, plx647-ome |
|
100
|
350
|
4eyjA |
Mapk13 complex with inhibitor |
|
117
|
350
|
4fa2A |
Human p38 alpha mitogen-activated kinase in complex with sb239063 |
|
103
|
359
|
4f7sA |
Crystal structure of human cdk8/cycc in the dmg-in conformation |
|
96
|
354
|
4f99A |
Human cdc7 kinase in complex with dbf4 and nucleotide |
|
103
|
350
|
4eymA |
Mapk13 complex with inhibitor |
|
123
|
348
|
4qteA |
Structure of erk2 in complex with vtx-11e, 4-{2-[(2-chloro-4-fluorophenyl)amino]-5-methylpyrimidin-4-yl}-n-[(1s)-1-(3-chlorophenyl)-2-hydroxyethyl]-1h-pyrrole-2-carboxamide |
|
81
|
277
|
4f0gA |
Crystal structure of the roco4 kinase domain from d. discoideum |
|
88
|
289
|
4hvhA |
Jak3 kinase domain in complex with 2-cyclopropyl-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((r)-2-hydroxy-1,2-dimethyl-propyl |
|
87
|
291
|
4e1zA |
Structure of mouse tyk-2 complexed to a 3-aminoindazole inhibitor |
|
105
|
301
|
4dt8A |
Crystal structure of aminoglycoside-2''-phosphotransferase type iva in complex with adenosine |
|
84
|
299
|
4eoqA |
Thr 160 phosphorylated cdk2 wt - human cyclin a3 complex with atp |
|
105
|
348
|
4e8aA |
The crystal structure of p38a map kinase in complex with pia24 |
|
86
|
298
|
4eokA |
Thr 160 phosphorylated cdk2 h84s, q85m, k89d - human cyclin a3 complex with the inhibitor nu6102 |
|
96
|
298
|
4e6qA |
Jak2 kinase (jh1 domain) triple mutant in complex with compound 12 |
|
86
|
297
|
4ehzA |
The jak1 kinase domain in complex with inhibitor |
|
86
|
296
|
4ek4A |
Crystal structure of the cdk2 in complex with aminopyrazole inhibitor |
|
103
|
298
|
4dtaA |
Crystal structure of f95m aminoglycoside-2''-phosphotransferase type iva in complex with adenosine |
|
109
|
351
|
4eh2A |
Human p38 map kinase in complex with np-f1 and rl87 |
|
109
|
351
|
4eh3A |
Human p38 map kinase in complex with np-f2 and rl87 |
|
88
|
333
|
4ec8A |
Structure of full length cdk9 in complex with cyclint and drb |
|
87
|
300
|
4eosA |
Thr 160 phosphorylated cdk2 wt - human cyclin a3 complex with the inhibitor ro3306 |
|
89
|
360
|
4e7wA |
Structure of gsk3 from ustilago maydis |
|
81
|
269
|
4enyA |
Crystal structure of pim-1 kinase in complex with (2e,5z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4-one |
|
106
|
435
|
4ejnA |
Crystal structure of autoinhibited form of akt1 in complex with n-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3h-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide |
|
101
|
293
|
4e6dA |
Jak2 kinase (jh1 domain) triple mutant in complex with compound 7 |
|
105
|
351
|
4eh8A |
Human p38 map kinase in complex with np-f7 and rl87 |
|
86
|
300
|
4eojA |
Thr 160 phosphorylated cdk2 h84s, q85m, k89d - human cyclin a3 complex with atp |
|
87
|
321
|
4ec9A |
Crystal structure of full-length cdk9 in complex with cyclin t |
|
107
|
377
|
4e93A |
Crystal structure of human feline sarcoma viral oncogene homologue (v-fes)in complex with tae684 |
|
80
|
298
|
4ek8A |
Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor |
|
92
|
290
|
4e4lA |
Jak1 kinase (jh1 domain) in complex with compound 30 |
|
88
|
290
|
4e20A |
Structure of mouse tyk-2 complexed to a 3-aminoindazole inhibitor |
|
87
|
298
|
4ek5A |
Crystal structure of the cdk2 in complex with aminopyrazole inhibitor |
|
85
|
298
|
4erwA |
Cdk2 in complex with staurosporine |
